Keybanc Maintains Overweight on Encompass Health, Raises Price Target to $150
Keybanc analyst Matthew Gillmor maintains Encompass Health (NYSE:EHC) with a Overweight and raises the price target from $147 to $150.
Share
Why It Matters
An analyst who likes Encompass Health raised their price prediction slightly. This shows they still think the company is in good shape.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.